Clinical Trials Sponsored by Maxygen ApS

Total 1191 results

AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

Prostatic Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin

Colorectal Cancer | Metastasis | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Cone Beam CT Scanning in Lung and Bladder Cancer.

Bladder Carcinoma | Small Cell Carcinoma | Lung Neoplasm

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer

Carcinoma, Small Cell

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

Glioma | Glioblastoma

Canada
Abdi Ibrahim Ilac San. ve Tic A.S.

Completed

Metabolic Syndrome Prevalence Study

Metabolic Syndrome

Turkey
Beth Israel Deaconess Medical Center
ALS Association

Completed

Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials

Amyotrophic Lateral Sclerosis

United States
Alberta Health services

Unknown

Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Hematologic Malignancy

Canada
Alberta Health services

Completed

Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases

Bone Neoplasms

Canada
Alberta Health services

Completed

HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

Low Grade Lymphoma

Canada
Alberta Health services

Completed

Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients

Colon Cancer

Canada
Alberta Health services

Completed

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

Peripheral Stem Cell/Marrow Transplant

Canada
Alberta Health services

Completed

Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function

Nasopharyngeal Neoplasms

Canada
Cedars-Sinai Medical Center
Penguin Cold Caps

Recruiting

Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma

Multiple Myeloma

United States
AHS Cancer Control Alberta
University of Calgary

Recruiting

mHealth Physical Activity Intervention for Young Cancer Survivors (AYA-PACT)

Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Trial of Hypofractionated Radiation Therapy for Glioblastoma

Glioblastoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Active, not recruiting

Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014

Neuroendocrine Tumors, NET

Canada
PharmaEssentia
Medpace, Inc.; EPS International; Brightech International

Active, not recruiting

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance (SURPASS ET)

Essential Thrombocythemia

United States, Canada, Korea, Republic of, China, Hong Kong, Singapore, Taiwan, Japan
AHS Cancer Control Alberta
Alberta Cancer Foundation

Unknown

A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Papillary Thyroid Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

Pancreatic Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

Non-small Cell Lung Cancer | Advanced Solid Malignancies

Canada
AHS Cancer Control Alberta
Transplant Genomics, Inc.

Unknown

RATIO: Rational Approach To Immuno-Oncology (RATIO)

Metastatic Melanoma

Canada
Spero Therapeutics
Simbec Research; QPS Holdings LLC

Completed

Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741

Healthy Volunteers

United Kingdom
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)

Head and Neck Neoplasms | Thyroid Neoplasms
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

Breast Cancer | Adverse Effect of Radiation Therapy

Canada
Kirsten Gruis
ALS Association

Completed

Study of Standard Noninvasive Positive Pressure Ventilation (NIPPV) and Low Expiratory Pressure NIPPV in ALS Patients

Amyotrophic Lateral Sclerosis

United States
Massachusetts General Hospital
ALS Therapy Development Institute

Completed

Gilenya in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

United States
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Glioma | Breast Cancer | Head and Neck Cancer | Carcinoma, Squamous Cell | Prostate Cancer | Carcinoma, Non-Small-Cell-Lung

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cel Lung Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) (SUPER)

Heart Failure | Renal Cell Carcinoma | Hypertension | Cardiotoxicity

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

MVCT Imaging Pilot Study Using Helical Tomotherapy

Cancer, Carcinoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
University of Alberta
AHS Cancer Control Alberta

Withdrawn

Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplication (TIF) Using EsophyX for the Treatment of GERD

Gastroesophageal Reflux Disease (GERD)

Canada
Alberta Health services

Completed

Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer

Head and Neck Cancer

Canada
Alberta Health services

Unknown

Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy (HER 2)

Breast Cancer

Canada
Abdi Ibrahim Ilac San. ve Tic A.S.

Completed

Efficacy and Safety Study of Udenafil Tablets in Erectile Dysfunction.

Erectile Dysfunction

Turkey
Alberta Health services

Terminated

Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients

Pain | Cancer

Canada
Alberta Health services

Unknown

Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors

Liver Tumors

Canada
Alberta Health services

Completed

Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.

Thyroid Neoplasms
Alberta Health services

Withdrawn

Presbyopia in Breast Cancer Survivors

Presbyopia
Alberta Health services

Completed

Review of Multimodality Management of Anaplastic Thyroid Cancer

Anaplastic Thyroid Cancer

Canada
Alberta Health services

Completed

Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community

Pain | Cancer | Hypercalcemia

Canada
Alberta Health services

Completed

Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer

Prostate Cancer

Canada

3

Subscribe